Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study
J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study
J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study
Submitted by
admin
on March 19, 2017 - 11:22am
Source:
Yahoo/Reuters
News Tags:
JNJ
Bayer
Xarelto
blood clots
bloodthinners
Headline:
J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study
Do Not Allow Advertisers to Use My Personal information